nitrous oxide has been researched along with Obesity, Morbid in 3 studies
Nitrous Oxide: Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.
dinitrogen oxide : A nitrogen oxide consisting of linear unsymmetrical molecules with formula N2O. While it is the most used gaseous anaesthetic in the world, its major commercial use, due to its solubility under pressure in vegetable fats combined with its non-toxicity in low concentrations, is as an aerosol spray propellant and aerating agent for canisters of 'whipped' cream.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacokinetic and pharmacodynamic properties of propofol indicate that this may be an appropriate agent for induction and maintenance of anesthesia in obese patients." | 2.67 | Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. ( Desmonts, JM; Farinotti, R; Haberer, JP; Servin, F, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JB | 1 |
| Lemmens, HJ | 1 |
| Collins, JS | 1 |
| Morton, JM | 1 |
| Curet, MJ | 1 |
| Brock-Utne, JG | 1 |
| Chalhoub, V | 1 |
| Yazigi, A | 1 |
| Sleilaty, G | 1 |
| Haddad, F | 1 |
| Noun, R | 1 |
| Madi-Jebara, S | 1 |
| Yazbeck, P | 1 |
| Servin, F | 1 |
| Farinotti, R | 1 |
| Haberer, JP | 1 |
| Desmonts, JM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Comparison of Cerebral Oximetry After Propofol-Based Total Intravenous Anesthesia and Sevoflurane Inhalation Anesthesia in Morbidly Obese Patients Undergoing LSG: a Prospective, Single-Blinded, Randomized, Parallel-Group Study.[NCT03946657] | Phase 4 | 60 participants (Actual) | Interventional | 2019-01-20 | Completed | ||
| Intravenous Anesthesia in Obese Patients: Propofol and Remifentanil Requirements[NCT00779844] | Phase 4 | 63 participants (Actual) | Interventional | 2008-12-31 | Terminated (stopped due to difficulty in recruiting) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for nitrous oxide and Obesity, Morbid
| Article | Year |
|---|---|
Nitrous oxide and laparoscopic bariatric surgery.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, Inhalation; Anesthetics, Inhalation; Body Mass Index; | 2005 |
Effect of vital capacity manoeuvres on arterial oxygenation in morbidly obese patients undergoing open bariatric surgery.
Topics: Adult; Analgesics, Non-Narcotic; Bariatric Surgery; Blood Gas Analysis; Blood Pressure; Carbon Dioxi | 2007 |
Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study.
Topics: Adult; Aged; Anesthesia, General; Drug Synergism; Female; Humans; Infusions, Intravenous; Male; Midd | 1993 |
Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study.
Topics: Adult; Aged; Anesthesia, General; Drug Synergism; Female; Humans; Infusions, Intravenous; Male; Midd | 1993 |
Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study.
Topics: Adult; Aged; Anesthesia, General; Drug Synergism; Female; Humans; Infusions, Intravenous; Male; Midd | 1993 |
Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study.
Topics: Adult; Aged; Anesthesia, General; Drug Synergism; Female; Humans; Infusions, Intravenous; Male; Midd | 1993 |